{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:58:18Z","timestamp":1783641498161,"version":"3.55.0"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Am. Soc. Mass Spectrom."],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.1021\/jasms.3c00217","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:49:58Z","timestamp":1697114998000},"page":"2491-2497","source":"Crossref","is-referenced-by-count":12,"title":["Rapid Intact Mass Analysis and Evaluation of the Separation Potential of Microfluidic Capillary Electrophoresis Mass Spectrometry for Oligonucleotides"],"prefix":"10.1021","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-7922","authenticated-orcid":true,"given":"Jennifer L.","family":"Lippens","sequence":"first","affiliation":[{"name":"Pivotal Attribute Sciences, Amgen, Thousand Oaks, California 91320, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath C.","family":"Timmons","sequence":"additional","affiliation":[{"name":"Pivotal Attribute Sciences, Amgen, Thousand Oaks, California 91320, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Welch","sequence":"additional","affiliation":[{"name":"908 Devices, Boston, Massachusetts 94720-1460, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"908 Devices, Boston, Massachusetts 94720-1460, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawnya G.","family":"Flick","sequence":"additional","affiliation":[{"name":"Pivotal Attribute Sciences, Amgen, Thousand Oaks, California 91320, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1614154"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2018.1454812"},{"key":"ref3\/cit3","unstructured":"mRNA medicines we are currently developing. Moderna. https:\/\/www.modernatx.com\/en-US\/research\/product-pipeline? (accessed\n2022\u201308\u201302)."},{"key":"ref4\/cit4","unstructured":"Product Pipeline: Pharmaceutical\nPipeline for New Drugs | Pfizer. https:\/\/www.pfizer.com\/science\/drug-product-pipeline (accessed\n2022\u201308\u201302)."},{"key":"ref5\/cit5","unstructured":"Amgen Pipeline. https:\/\/www.amgenpipeline.com (accessed 2022\u201308\u201302)."},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.03.008"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2007.01.042"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113105"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c01934"},{"key":"ref10\/cit10","unstructured":"McCarthy, S. M.; Gilar, M. Hexylammonium Acetate as an Ion-Pairing Agent for IP-RP LC Analysis of Oligonucleotides; Waters Corporation, 2016."},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2016.02.057"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-016-1500-3"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2021-0084"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2015.10.030"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415474"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.0c00179"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8107"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2007.09.005"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2013.06.050"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2021-0134"},{"key":"ref21\/cit21","first-page":"486","volume-title":"Exploring Chemical Analysis","author":"Harris D. C.","year":"2001","edition":"2"},{"key":"ref22\/cit22","unstructured":"<1053>\nCapillary Electrophoresis, 2020. https:\/\/www.usp.org\/sites\/default\/files\/usp\/document\/harmonization\/biotechnology\/harmonization-september-2019-m859.pdf."},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113218"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2018.06.006"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.0c00424"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9872.1000359"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2787(1996)15:2<67::AID-MAS1>3.0.CO;2-8"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-0305(00)00174-4"},{"key":"ref29\/cit29","first-page":"303","volume-title":"Mass Spectrometry of Nucleosides and Nucleic Acids","author":"Fabris D.","year":"2010"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1039\/C6AN00453A"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8696"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1021\/jasms.0c00380"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-014-0905-0"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1021\/ac5044016"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.8b03632"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1021\/ac0618674"},{"key":"ref37\/cit37","unstructured":"International\nConference on Harmonisation, Guideline for Good Clinical\nPractice.  Guidance for Industry: Q2B Validation of\nAnalytical Procedures: Methodology. https:\/\/www.fda.gov\/media\/71725\/download (accessed 2022\u201309\u201302)."}],"container-title":["Journal of the American Society for Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jasms.3c00217","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/jasms.3c00217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:36:33Z","timestamp":1698827793000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/jasms.3c00217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"alternative-id":["10.1021\/jasms.3c00217"],"URL":"https:\/\/doi.org\/10.1021\/jasms.3c00217","relation":{},"ISSN":["1044-0305","1879-1123"],"issn-type":[{"value":"1044-0305","type":"print"},{"value":"1879-1123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]}}}